Interview report presentation / Case Study

This case study explores the journey of an 81-year-old patient seeking Zepbound to enhance life quality and simplify treatment, highlighting Medicare access barriers to GLP-1 drugs. It analyzes legal and procedural hurdles, offering insights from the prior authorization process and proposes strategies, including advocating broader CMS coverage for prediabetes and obesity. The study emphasizes the economic and health benefits of expanded access and improved policies.